Nabriva Therapeutics

$0.4355
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.012 (+2.85%) Today
+$0.0025 (+0.58%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell NBRV and other stocks, options, and ETFs commission-free!

About NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland, also called Nabriva Therapeutics, is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland. The listed name for NBRV is Nabriva Therapeutics plc Ordinary Shares Ireland.

CEO
Theodore R. Schroeder
Employees
162
Headquarters
Dublin, Dublin
Founded
2005
Market Cap
65.29M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.50M
High Today
$0.4469
Low Today
$0.4225
Open Price
$0.439
Volume
1.15M
52 Week High
$2.04
52 Week Low
$0.385

Collections

NBRV Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like